Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Epo Biosimilar'

Epo Biosimilar published presentations and documents on DocSlides.

FDA Approves First Biosimilar Sandozs Zarxio By Jennif

FDA Approves First Biosimilar Sandozs Zarxio By Jennif

  • pamella-moone
  • 2 Slides

Dienes Maria E Doukas Christopher J Betti PhD ...

What You Need to Know About

What You Need to Know About

  • marina-yarberry
  • 17 Slides

Biosimilars. : Products, Recent Deals, IP Issues ...

Biosimilar biological productEvaluation by the FDA

Biosimilar biological productEvaluation by the FDA

  • alida-meadow
  • 100 Slides

oducts used to diagnose, prevent, of diseases and ...

A QUM partnership approach to regulating

A QUM partnership approach to regulating

  • liane-varnes
  • 18 Slides

biosimilars. in Australia. David Lim, Evan Siege...

Biosimilars in the united states – Update on FDA Impleme

Biosimilars in the united states – Update on FDA Impleme

  • test
  • 37 Slides

James C. Shehan. Hyman, Phelps & McNamara, P....

Is Australia ready for

Is Australia ready for

  • liane-varnes
  • 12 Slides

biosimilar. . ?. David Lim, Julie Hepworth, Lis...

Phil Johnson MS

Phil Johnson MS

  • stefany-barnette
  • 56 Slides

RPh. Safe School Meds, Principle Partner. Moffitt...

Conference Series LLC

Conference Series LLC

  • alida-meadow
  • 49 Slides

Conferences. Conference Series LLC . is a pioneer...

Acceptable changes in quality attributes of glycosylated bi

Acceptable changes in quality attributes of glycosylated bi

  • debby-jeon
  • 19 Slides

Schiestl M, Stangler T, Torella C, et al. . Nat B...

Biosimilars

Biosimilars

  • lindy-dunigan
  • 22 Slides

Knowledge Connect Slide Resource. This slide dec...

Biosimilars in RA: A Blessing or a Curse?

Biosimilars in RA: A Blessing or a Curse?

  • conchita-marotz
  • 0 Slides

Introduction/Overview . What Is a Biosimilar?. Di...

Concurrent Session 1B

Concurrent Session 1B

  • yoshiko-marsland
  • 0 Slides

View . from the Life Sciences . Industry. Moderat...

US Regulatory Pathway For Biosimilars

US Regulatory Pathway For Biosimilars

  • cheryl-pisano
  • 0 Slides

Practical Legal/Regulatory Considerations Arising...

Biosimilars 2012 AIPLA Webinar

Biosimilars 2012 AIPLA Webinar

  • stefany-barnette
  • 0 Slides

September 25, 2012. 1. Denise. Kettelberger, PhD...

Biosimilars in the Real World

Biosimilars in the Real World

  • liane-varnes
  • 0 Slides

Introduction/Overview . PLANETRA Extension Study:...

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

  • calandra-battersby
  • 0 Slides

OMICS Group Biosimilars 2015 Birmingham, UK. 10-1...

Analytical Similarity Assessment: Practical Challenges and Statistical Perspectives

Analytical Similarity Assessment: Practical Challenges and Statistical Perspectives

  • alida-meadow
  • 0 Slides

Richard Montes, Ph.D.. Hospira. , a Pfizer compan...

High-resolution SPR surrogate potency assay to facilitate comparability and biosimilar studies

High-resolution SPR surrogate potency assay to facilitate comparability and biosimilar studies

  • test
  • 0 Slides

Veronica Fridh, GE Healthcare, Uppsala, Sweden No...

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

  • stefany-barnette
  • 0 Slides

OMIC Group Biosimilars 2014. Hyderabad India. 27-...

Understanding Biologics Biologics and Biosimilars

Understanding Biologics Biologics and Biosimilars

  • calandra-battersby
  • 0 Slides

Animation: What Are Biologics?. Production of Bio...

Biological Products: concepts, naming,

Biological Products: concepts, naming,

  • faustina-dinatale
  • 0 Slides

interchangeability,extrapolation. and safety. Dr...

Faculty Leonard H. Calabrese, DO

Faculty Leonard H. Calabrese, DO

  • trish-goza
  • 0 Slides

Professor of Medicine. Cleveland Clinic Lerner Co...

Applying Biosimilars in Hematologic Cancers

Applying Biosimilars in Hematologic Cancers

  • conchita-marotz
  • 0 Slides

This program will include a discussion of off-lab...

MODULE 8. Follow-on drugs: generic, biosimilar

MODULE 8. Follow-on drugs: generic, biosimilar

  • alida-meadow
  • 0 Slides

& non-biological similar medicinal products ....

United Spinal Association

United Spinal Association

  • alida-meadow
  • 0 Slides

August, 2014. Biologics & Biosimilars: . An O...

Comparison of US/EU Biosimilar

Comparison of US/EU Biosimilar

  • danika-pritchard
  • 0 Slides

Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...

Biosimilars & EU regulation

Biosimilars & EU regulation

  • karlyn-bohler
  • 0 Slides

Alice DOMINIQUE - M2 AREIPS. 1. Content. 2. Defin...

About OMICS Group OMICS Group International is an amalgamation of 

About OMICS Group OMICS Group International is an amalgamation of 

  • sherrill-nordquist
  • 0 Slides

Open Access publications.  and worldwide interna...

ASBM Biosimilars US Prescribers and Biosimilars Naming

ASBM Biosimilars US Prescribers and Biosimilars Naming

  • min-jolicoeur
  • 0 Slides

Kevin Olson, CEO. Industry Standard Research. Kev...

PhAMA Position on Biosimilar Medicines

PhAMA Position on Biosimilar Medicines

  • celsa-spraggs
  • 0 Slides

Ms. Leah Goodman. Contents. Key Messages. An Over...

Application of Biosimilars in RA IN Clinical Practice:

Application of Biosimilars in RA IN Clinical Practice:

  • conchita-marotz
  • 0 Slides

Key Issues and Challenges.  . Introduction. Diff...

PSHP President’s Update

PSHP President’s Update

  • olivia-moreira
  • 0 Slides

PSHP Annual Assembly. October 28, 2015. Matt Scol...

National Pharmacy Practice

National Pharmacy Practice

  • debby-jeon
  • 0 Slides

Gene Dorr . Area Vice President, PBM Consulting. ...

Biosimilar Biological Products

Biosimilar Biological Products

  • luanne-stotts
  • 0 Slides

2016 . Clinical Investigator . Training Course. S...

Comparison of US/EU Biosimilar

Comparison of US/EU Biosimilar

  • myesha-ticknor
  • 0 Slides

Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...

U.S. Biosimilars: An Introduction

U.S. Biosimilars: An Introduction

  • calandra-battersby
  • 0 Slides

Disclaimers. :. By 2016, 7 of the top 10 pharmace...

Comparison of US/EU Biosimilar

Comparison of US/EU Biosimilar

  • aaron
  • 0 Slides

Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...

Phil Johnson MS RPh Safe School Meds, Principle Partner

Phil Johnson MS RPh Safe School Meds, Principle Partner

  • yoshiko-marsland
  • 0 Slides

Moffitt Cancer Center, Director of Pharmacy (Reti...

Latin American Physician Perspectives on Biosimilars

Latin American Physician Perspectives on Biosimilars

  • celsa-spraggs
  • 0 Slides

Presented at the . Latin American Biologics/Biosi...

Biosimilars in emerging markets- regulatory and Commercial considerations

Biosimilars in emerging markets- regulatory and Commercial considerations

  • jane-oiler
  • 0 Slides

OMIC Group. Biosimilars 2104. Hyderabad. India. 2...

Copyright © 2024 DocSlides. All Rights Reserved